{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:11:08Z","timestamp":1789992668233,"version":"4.0.1"},"reference-count":17,"publisher":"FapUNIFESP (SciELO)","issue":"8","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.20260528","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:26:51Z","timestamp":1789990011000},"source":"Crossref","is-referenced-by-count":0,"title":["Prasugrel 5 mg in acute coronary syndromes: indications and clinical outcomes"],"prefix":"10.1590","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-1752","authenticated-orcid":false,"given":"Luiz Fernando Leite","family":"Tanajura","sequence":"first","affiliation":[{"name":"Institute Dante Pazzanese of Cardiology,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4854-3151","authenticated-orcid":false,"given":"Jos\u00e9 Henrique","family":"Delamain","sequence":"additional","affiliation":[{"name":"Institute Dante Pazzanese of Cardiology,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-1715","authenticated-orcid":false,"given":"Andr\u00e9","family":"Labrunie","sequence":"additional","affiliation":[{"name":"Institute Dante Pazzanese of Cardiology,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8958-162X","authenticated-orcid":false,"given":"Gabriel Brand\u00e3o Neves de","family":"Souza","sequence":"additional","affiliation":[{"name":"Institute Dante Pazzanese of Cardiology,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5374-0008","authenticated-orcid":false,"given":"Luiz Gustavo de Oliveira","family":"Tanajura","sequence":"additional","affiliation":[{"name":"Institute Dante Pazzanese of Cardiology,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics \u2013 2020 update: a report from the American Heart Association","volume":"141","author":"Virani SS","year":"2020","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne RA","year":"2023","journal-title":"Eur Heart J"},{"key":"ref3","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao SV","year":"2025","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.4244\/EIJ-D-21-00904","article-title":"Antiplatelet therapy after percutaneous coronary intervention","volume":"17","author":"Angiolillo DK","year":"2022","journal-title":"Eurointervention"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","article-title":"Prasugrel compared with high- loading and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention. The PRINCIPLE TIMI 44 trial","volume":"116","author":"Wiviott SD","year":"2007","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes. The TRITON TIMI 38 trial","volume":"357","author":"Wiviott SD","year":"2007","journal-title":"N Engl J Med"},{"issue":"20","key":"ref7","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.jacc.2012.08.964","article-title":"Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in high-body-weight patients. Results from the FEATHER trial","volume":"60","author":"Erlinge D","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2013.05.023","article-title":"Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary disease patients","volume":"62","author":"Erling D","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe MT","year":"2012","journal-title":"N Engl J Med"},{"issue":"23","key":"ref10","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/CIRCULATIONAHA.118.033952","article-title":"Prasugrel in the elderly (Editorial)","volume":"137","author":"Bangalore S","year":"2018","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.117.032180","article-title":"Comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization","volume":"137","author":"Savonitto S","year":"2018","journal-title":"Circulation"},{"issue":"10257","key":"ref12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(20)31791-8","article-title":"Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial","volume":"96","author":"Kim HS","year":"2020","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Sch\u00fcpke S","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7326\/M20-1806","article-title":"Age- and weight-adapted dose of prasugrel versus standard dose of ticagrelor in patients with acute coronary syndromes: results from a randomized trial","volume":"173","author":"Menichelli M","year":"2020","journal-title":"Ann Intern Med"},{"issue":"14","key":"ref15","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.4244\/EIJ-D-25-00331","article-title":"One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduce dose: the 4D ACS randomized trial","volume":"21","author":"Jang Y","year":"2025","journal-title":"Eurointervention"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy in patients with acute coronary syndrome. The STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe H","year":"2022","journal-title":"JAMA Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.123.066720","article-title":"An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial","volume":"149","author":"Natsuaki M","year":"2023","journal-title":"Circulation"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302026000802602&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:26:53Z","timestamp":1789990013000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302026000802602&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0104-42302026000802602"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20260528","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20260528"}}